<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
September 16, 1996
--------------------------------------------
Date of Report (Date of earliest event reported)
Renal Treatment Centers, Inc.
-------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 1-14142 23-2518331
- ----------------- -------------- --------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification
Number)
1180 W. Swedesford Road, Building 2, Suite 300, Berwyn, PA 19312
- ------------------------------------------------------------------------------
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code: 610/644-4796
------------
<PAGE>
Item 5. Other Events
- ------- ------------
On July 23, 1996, Renal Treatment Centers, Inc. (the "Company") acquired two
affiliated dialysis centers and related assets from Panama City Artificial
Kidney Center, Inc. and North Florida Artificial Kidney Center, Inc. Both of
the dialysis centers are located in Florida. The acquisition was structured as
a merger of the acquired corporations into a wholly-owned subsidiary of the
Company. The Company has accounted for the transaction under the pooling-of-
interests method of accounting.
To provide a period that the Company can use to demonstrate that the risk
sharing requirements for pooling-of-interests accounting treatment (as required
by the Securities and Exchange Commission's ASR. No. 135 and SAB No. 65) have
occurred, the condensed combined unaudited results of operations for the one
month ended August 31, 1996, which cover at least 30 days of post-merger
operations, are being published by the filing of this report.
The operating results for the one-month period ended August 31, 1996, are not
necessarily indicative of the results that may be expected for the three- and
nine-month periods ending September 30, 1996, or the year ending December
31,1996. In the opinion of management, all adjustments (consisting only of
normal recurring accruals) considered necessary for a fair presentation, have
been included.
Renal Treatment Centers, Inc. and Subsidiaries
Condensed Combined Income Statements
(Unaudited)
For the
Month Ended
August 31,
1996
Total net revenue $ 20,797,197
Net income 1,720,073
Net income available to
shareholders 2,119,446
Net income per share fully
diluted $0.07
2
<PAGE>
SIGNATURES
- ----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
RENAL TREATMENT CENTERS, INC.
Date: September 16, 1996 By:/s/ Frederick C. Jansen
-------------------------------------
Frederick C. Jansen
Executive Vice President
3
